The lysosomal cysteine proteases

Annual Review of Biophysics and Biomolecular Structure

Volumn 28, Issue , 1999, Pages 181-204

  McGrath, Mary E ^a  

^a Axys Pharmaceuticals Inc   (United States)

Author keywords

Cathepsins; Crystallography; Papain; Structure based drug design; Thiol

Indexed keywords

CATHEPSIN B; CATHEPSIN H; CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; CYSTEINE PROTEINASE; ENZYME PRECURSOR; PAPAIN;

ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; LYSOSOME; NOMENCLATURE; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

MAMMALIA;

EID: 0032986028     PISSN: 10568700     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.biophys.28.1.181     Document Type: Article

References (112)

1. 1. Baker EN, Dodson EJ. 1980. Crystallographic refinement of the structure of actinidin at 1.7 Å resolution by fast Fourier least-squares methods. Acta Crystallogr. A36:559-72
2. 2. Bano B, Kunapuli SP, Bradford HN, Colman RW. 1996. Structural requirements for cathepsin B and cathepsin H inhibition by kininogens. J. Protein Chem. 15:519-25
3. 3. Barrett A. 1980. Cathepsin G. Methods Enzymol. 80:561-65
4. 4. Barrett A, McDonald J. 1980. Mammalian Proteases. New York: Academic
5. 5. Barrett AJ, Rawlings ND, Davies ME, Machleidt W, Salveson G, et al. 1986. In Proteinase Inhibitors, ed. AJ Barrett, G Salvesen. Amsterdam: Elsevier. 661 pp.
6. 6. Bart G, Frame MJ, Carter R, Coombs GH, Mottram JC. 1997. Cathepsin B-like cysteine proteinase-deficient mutants of Leishmania mexicana. Mol. Biochem. Parasitol. 88:53-61
7. 7. Baudys M, Meloun B, Gan-Erdene T, Fusek M, Mares M, et al. 1991. S-S bridges of cathepsin B and H from bovine spleen: a basis for cathepsin B model building and possible functional implications for discrimination between exo-and endopeptidase activities among cathepsins B, H, and L. Biomed. Biochim. Acta 50:569-637
8. 8. Baudys M, Meloun B, Gan-Erdene T, Pohl J, Kostka V. 1990. Disulfide bridges of bovine spleen cathepsin B. Biol. Chem. Hoppe-Seyler 371:485-91
9. 9. Bernstein FC, Koetzle TF, Williams GJB, Meyer EF, Brice MD, et al. 1977. The Protein Data Bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 112:535-42
10. 10. Berti PJ, Storer AC. 1995. Alignment/ phylogeny of the papain superfamily of cysteine proteases. J. Mol. Biol. 246:273-83
11. 11. Brömme D, Bonneau PR, Lachance P, Storer AC. 1994. Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L-and cathepsin B-like specificity. J. Biol. Chem. 269:30238-42
12. 12. Brömme D, Bonneau PR, Lachance P, Wiederanders B, Kirschke H, et al. 1993. Functional expression of human cathepsin S in Saccharomyces cerevisiae. J. Biol. Chem. 268:4832-38
13. 13. Brömme D, Klaus JL, Okamoto K, Rasnick D, Palmer JT. 1996. Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L. Biochem. J. 315:85-89
14. 14. Brömme D, McGrath ME. 1996. High level expression and crystallization of recombinant human cathepsin S. Protein Sci. 5:789-91
15. 15. Brömme D, Okamoto K. 1995. Human cathepsin O2: a novel cysteine protease highly expressed in osteoclastoma and ovary. Biol. Chem. Hoppe-Seyler 376: 379-84
16. 16. Brömme D, Okamoto K, Wang BB, Biroc S. 1996. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. J. Biol. Chem. 271:2126-32
17. 17. Brömme D, Steinert A, Friebe S, Fittkau S, Wiederanders B, et al. 1989. The specificity of bovine spleen cathepsin S. Biochem. J. 264:475-81
18. 18. Brünger AT, Rice LM. 1997. Crystallographic Refinement by Simulated Annealing: Methods and Applications. Methods Enzymol. 277:243-69
19. 19. Caffrey CR, Ruppel A. 1997. Affinity isolation and characterization of the cathepsin B-like proteinase Sj31 from Schistosoma japonicum. J. Parasitol. 83:1112-18
20. 20. Carmona E, Dufour E, Plouffe C, Takebe S, Mason P, et al. 1996. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry 35:8149-57
21. 21. Chen Y, Plouffe C, Menard R, Storer AC. 1996. Delineating functionally important regions and residues in the cathepsin B propeptide for inhibitory activity. FEBS Lett. 393:24-26
22. 22. Coulombe R, Grochulski P, Sivaraman J, Menard R, Mort J, et al. 1996. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J. 15:5492-503
23. 23. Cygler M, Sivaraman J, Grochulski P, Coulomb R, Storer AC, et al. 1996. Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion. Structure 4:405-16
24. 24. Del Nery E, Juliano MA, Meldal M, Svendsen I, Scharfstein J, et al. 1997. Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides. Biochem. J. 323:427-33
25. 25. Dolenc I, Turk B, Pungercic G, Ritonja A, Turk V. 1995. Oligomeric structure and substrate induced inhibition of human cathepsin C. J. Biol. Chem. 270:21626-31
26. 26. Drake FH, Dodds RA, James IE, Connor JR, Debouck C, et al. 1996. Cathepsin K, but not cathpsins B, L, or S, is abundantly expressed in human osteoclasts. J. Biol. Chem. 271:12511-16
27. 27. Drenth J, Jansonius JN, Koekoek R, Swen HM, Wolthers BG. 1968. Structure of papain. Nature 218:929-32
28. 28. Drenth J, Kalk KH, Swen HM. 1976. Binding of chloromethyl ketone substrate analogues to crystalline papain. Biochemistry 15:3731-18
29. 29. Esser RE, Angelo RA, Murphey MD, Watts LM, Thornburg LP, et al. 1994. Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. Arthritis Rheum. 37:236-47
30. 30. Feng M-H, Chan SL, Xiang YF, Huber CP, Lim C. 1996. The binding mode of an E-64 analog to the active site of cathepsin B. Protein Eng. 9:977-86
31. 31. Fujishima A, Imai Y, Nomura T, Fujisawa Y, Yamamoto Y, et al. 1997. The crystal structure of human cathepsin L complexed with E-64. FEBS Lett. 407:47-50
32. 32. Gelb BD, Edelson JG, Desnick RJ. 1995. Linkage of pycnodysostosis to chromosome Iq21 by homozygosity mapping. Nat. Genet. 10:235-57
33. 33. Gelb BD, Shi G-P, Chapman HA, Desnick RJ. 1996. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236-68
34. 34. Gillmor SA, Craik C, Fletterick RJ. 1997. Structural determinants of specificity in the cysteine protease cruzain. Protein Sci. 6:1603-11
35. 35. Green GD, Kembhavi AA, Davies ME, Karrett AJ. 1984. Cystatin-like cysteine proteinase inhibitors from human liver. Biochem. J. 218:939-46
36. 36. Groves MR, Taylor MA, Scott M, Cummings NJ, Pickersgill RW, et al. 1996. The prosequence of procaricain forms an alpha-helical domain that prevents access to the substrate-binding cleft. Structure 4:1193-203
37. 37. Guncar G, Podobnik M, Pungercar J, Strukelj B, Turk V, et al. 1998. Crystal structure of porcine cathepsin H determined at 2.1 Å resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopcptidasc function. Structure 6:51-61
38. 38. Hart G, Andrews N, Mills AA, Engel J, Smith R, et al. 1993. Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of T. cruzi. Mol. Biochem. Parasitol. 58:17-24
39. 39. Heinemann U, Pal GP, Hilgenfeld R, Saenger W. 1982. Crystal and molecular structure of the sulfhydryl protease calotropin at 3.2 Å resolution. J. Mol. Biol. 161:591-606
40. 40. Henson H, Frohne M. 1976. Crystalline leucine aminopeptidase from lens (alpha-aminoacyl-peptide hydrolase; EC 3.4.11.1). Methods Enzymol. 45:504-20
41. 41. Heu MS, Kim HR, Cho DM, Godber JS, Pyeun JH. 1997. Purification and characterization of cathepsin L-like enzyme from the muscle of anchovy, Engraulis japonica. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 118:523-29
42. 42. Jia Z, Hasnain S, Hirama T, Lee X, Mort JS, et al. 1995. Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. J. Biol. Chem. 270:5527-33
43. 43. Kakegawa H. 1993. Participation of cathepsin L in bone resorption. FEBS Lett. 321:247-50
44. 44. Kamphuis IG, Kalk KH, Swarte MBA, Drenth J. 1984. Structure of papain refined at 1.65 Å resolution. J. Mol. Biol. 179:233-56
45. 45. Katerelos NA, Taylor MA, Scott M, Goodenough PW, Pickersgill RW. 1996. Crystal structure of a caricain D158E mutant in complex with E-64. FEBS Lett. 392:35-39
46. 46. Katunuma N, Kominami E. 1987. Rev. Physiol. Biochem. Pharmacol. 108:1-20
47. 47. Keillor JW, Niverov AA, Brown RS. 1994. Catalysis of amide hydrolysis and formation under neutral conditions by a zwitterionic imidazolium thiolate. J. Am. Chem. Soc. 116:4669-73
48. 48. Kennett CN, Cox SW, Eley BM. 1997. Ultrastructural localization of cathepsin B in gingival tissue from chronic periodontitis patients. Histochem. J. 29:727-34
49. 49. Kirschke H, Schmidt I, Wiederanders B. 1986. Cathepsin S: The cysteine proteinase from bovine lymphoid tissue is distinct from cathepsin L. Biochem. J. 240:455-59
50. 50. Kirschke H, Wiederanders B, Brömme D, Rinne A. 1989. Cathepsin S from bovine spleen: purification, distribution, intracellular localization, and action on proteins. Biochem. J. 246:467-73
51. 51. Kortemme T, Creighton TE. 1995. Ionisation of cysteine residues at the termini of model alpha-helical peptides. Relevance to unusual thiol pKa values in proteins of the thioredoxin family. J. Mol. Biol. 253:799-812
52. 52. Krasko A, Gamulin V, Seack J, Steffen R, Schroder HC, et al. 1997. Cathepsin, a major protease of the marine sponge Geodia cydonium: purification of the enzyme and molecular cloning of cDNA. Mol. Mar. Biol. Biotechnol. 6:296-307
53. 53. Kraulis P. 1991. Molscript-A program to produce both detailed and specific plots of protein structures. J. Appl. Crystallog. 24:946-50
54. 54. Liao JC, Lenney JF. 1984. Cathepsins J and K: high molecular weight cysteine proteinases from human tissues. Biochem. Biophys. Res. Commun. 124:909-16
55. 55. Littlewood-Evans AJ, Bilbe G, Bowler WB, Farley D, Wlodarski B, et al. 1997. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 57:5386-90
56. 56. Maes D, Bouckaert J, Poortmans F, Wyns L, Looze Y. 1996. Structure of chymopapain at 1.7 Å resolution. Biochemistry 35:16292-98
57. 57. McDonald JK, Barrett AJ. 1986. Mammalian Proteases, Vol. 2. New York: Academic. 357 pp.
58. 58. McGrath ME, Eakin AE, Engel J, McKerrow JH, Craik CS, et al. 1995. The crystal structure of cruzain: a therapeutic target for Chagas' disease. J. Mol. Biol. 247:251-59
59. 59. McGrath ME, Klaus JL, Barnes MG, Bromme D. 1997. Crystal structure of human cathepsin K completed with a potent inhibitor. Nat. Struct. Biol. 4:105-9
60. 60. McGrath ME, Palmer JT, Brömme D, Somoza JR. 1998. Crystal structure of human cathepsin S. Protein Sci. 7:1294-302
61. 61. Meirelles MNL, Juliano L, Carmona E, Silva SG, Costa EM, et al. 1992. Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Mol. Biochem. Parasitol. 52:175-84
62. 62. Mellor GW, Thomas HW, Topham CM, Brocklehurst K. 1993. The ionization characteristics of the Cys-25-His-159 interactive system and of the modulatory group of papain. Resolution of ambiguity by electronic perturbation of the quasi 2-mercaptopyridine leaving group in a new pyrimidyl disulphide reactivity probe. Biochem. J. 290:289-96
63. 63. Menard R, Carriere J, LaFlamme P, Plouffe C, Khouri H, et al. 1991. Contribution of the glutamine 19 side chain to transition-state stabilization in the oxyanion hole of papain. Biochemistry 30:8924-28
64. 64. Menard R, Khouri H, Plouffe C, Laflamme P, Dupras R, et al. 1991. Importance of hydrogen-bonding interactions involving the side chain of Asp 158 in the catalytic mechanism of papain. Biochemistry 30:5531-18
65. 65. Ménard R, Khouri HE, Plouffe C, Dupras R, Ripoll D, et al. 1990. A protein engineering study of the role of aspartate 158 in the catalytic mechanism of papain. Biochemistry 29:6706-13
66. 66. Musil D, Zucic D, Turk D, Engh RA, Mayr I, et al. 1991. The refined 2.15 Å X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J. 10:2321-30
67. 67. Nagler DK, Storer AC, Portara FCV, Carmona E, Juliano L, et al. 1997. Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Biochemistry 36:12608-15
68. 68. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, et al. 1998. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280:450-53
69. 69. Nelson JW, Creighton TE. 1994. Reactivity and ionization of the active site cysteine residues of DsbA, a protein required for disulfide bond formation in vivo. Biochemistry 33:5974-83
70. 70. O'Hara BP, Hemmings AM, Buttle DJ, Pearl LH. 1995. Crystal structure of glycyl endopeptidase from carica papaya: a cysteine endopeptidase of unusual substrate specificity. Biochemistry 34:13190-95
71. 71. Otto H-H, Schirmeister T. 1997. Cysteine protease and their inhibitors. Chem. Rev. 97:133-71
72. 72. Palmer JT, Rasnick D, Klaus JL. 1995. Vinyl sulfones as mechanism-based cysteine protease inhibitors. J. Med. Chem. 38:3193-96
73. 73. Petanceska S, Burke S, Watson SJ, Devi L. 1994. Differential distribution of messenger RNAs for cathepsins B, L, and S in adult rat brain: an in situ hybridization study. Neuroscience 59:729-38
74. 74. Pickersgill RW, Harris GW, Garman E. 1992. Structure of monoclinic papain at 1.6 Å resolution. Acta Crystallogr. B 48:59
75. 75. Pickersgill RW, Rizkallah P, Harris GW, Goodenough PW. 1991. Determination of the structure of papaya protease omega. Acta Crystallogr. B 47:766-71
76. 76. Pinitglang S, Watts AB, Patel M, Reid JD, Noble MA, et al. 1997. A classical enzyme active center motif lacks catalytic competence until modulated electrostatically. Biochemistry 36:9968-82
77. -/(His)-Im+H ion pair in one type of serine proteinase architecture by kinetic and computational studies on chemically mutated subtilisin variants. J. Mol. Biol. 257:1088-111
78. 78. Podobnik M, Kuhelj R, Turk V, Turk D. 1997. Crystal structure of the wild-type human procathepsin B at 2.5 Å resolution reveals the native active site of a papain-like cysteine protease zymogen. J. Mol. Biol. 271:774-88
79. 79. Polgar L. 1974. Mercaptide-imidazolium ion-pair: the reactive nucleophile in papain catalysis. FEBS Lett. 47:15-18
80. 80. Riese RJ, Mitchell RN, Villadangos JA, Karp ER, DeSanctis GT, et al. 1998. Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 101:2351-63
81. 81. Riese RJ, Wolf PR, Bromme D, Natkin LR, Villadangos JA, et al. 1996. Essential role for cathepsin S in MHC class H-associated invariant chain processing and peptide loading. Immunity 4:357-66
82. 82. Rosenthal PJ. 1995. Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites. Exp. Parasitol. 80:272-81
83. 83. Rullmann JAC, Bellido MN, van Duijnen PT. 1989. The active site of papain: allatom study of interactions with protein matrix and solvent. J. Mol. Biol. 206:101-18
84. 84. Santamaria I, Velasco G, Cazorla M, Fueyo A, Campo E, et al. 1998. Cathepsin L2, a novel cysteine proteinase produced by breast and colorectal carcinomas. Cancer Res. 58:1624-30
85. 85. Schechter I, Berger A. 1967. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27:157-62
86. 86. Schick C, Bemberton PA, Shi GP, Kamachi Y, Cataltepe S, et al. 1998. Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. Biochemistry 37:5258-66
87. 87. Schroeder E, Phillips C, Garman E, Harlos K, Crawford C. 1993. X-ray crystallographic structure of a papain-leupeptin complex. FEBS Lett. 315:38
88. 88. Sharma A, Padwal-Desai S, Ninjoor V. 1989. Intracellular hydrolases of Aspergillus parasiticus and Aspergillus flavus. Biochem. Biophys. Res. Commun. 159:464-71
89. 89. Shaschke N, Assfalg-Machleidt I, Machleidt W, Moroder L. 1998. Substrate/ propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors. FEBS Lett. 421:80-82
90. 90. Sloane BF, Honn KV. 1984. Cysteine proteinases and metastasis. Cancer Metastasis Rev. 3:249-63
91. 91. Stubbs MT, Laber B, Bode W, Huber R, Jerala R, et al. 1990. The refined 2.4 Å X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J. 9:1939-47
92. 92. Takahashi T, Tang J. 1981. Cathepsin D from porcine and bovine spleen. Methods Enzymol. 80:565-81
93. 93. Tezuka K, Tezuka Y, Maejima A, Sato T, Nemoto K, et al. 1994. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J. Biol. Chem. 269:1106-9
94. 94. Thompson SK, Halbert SM, Bossard MJ, Tomaszek TA, Levy MA, et al. 1997. Design of potent and selective human cathepsin K inhibitors that span the active site. Proc. Natl. Acad. Sci. 94:14249-54
95. 95. Tsushima H, Ueki A, Matsuoka Y, Mihara H, Hopsu-Havu VK. 1991. Characterization of a cathepsin H-like enzyme from a human melanoma cell line. Int. J. Cancer 48:726-32
96. 96. Turk B, Stoka V, Bjork I, Boudier C, Johansson G, et al. 1995. High-affinity binding to two molecules of cysteine proteinases to low-molecular-weight kininogen. Protein Sci. 4:1874-80
97. 97. Turk D, Guncar G, Podobnik. M, Turk B. 1998. Revised definition of substrate binding sites of papain-like cysteine proteases. Biol. Chem. 379:137-47
98. 98. Turk D, Podobnik M, Kuhelj R, Dolinar M, Turk V. 1996. Crystal structures of human procathepsin B at 3.2 and 3.3 Å resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide. FEBS Lett. 384:211-14
99. 99. Turk D, Podobnik M, Popovic T, Katunuma N, Bode W, et al. 1995. Crystal structure of cathepsin B inhibited with CA030 at 2.1 Å resolution: a basis for the design of specific epoxysuccinyl inhibitors. Biochemistry 34:4791-97
100. 100. Turnsek T, Kregar I, Lebez D. 1975. Acid sulfhydryl protease from calf lymph nodes. Biochim. Biophys. Acta 403:514-20
101. 101. Varughese KI, Ahmed FR, Carey PR, Hasnain S, Huber CP, et al. 1989. Crystal structure of a papain-E-64 complex. Biochemistry 28:1330-32
102. 102. Villadangos JA, Riese RJ, Peters C, Chapman HA, Ploegh HL, 1997. Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J. Exp. Med. 186:549-60
103. 103. Willenbrock F, Brocklehurst K. 1984. Natural variation in enzymes as a tool in the study of mechanism exemplified by a comparison of the catalytic-site structure and characteristics of cathepsin B and papain. pH-Dependent kinetics of the reactions of cathepsin B from bovine spleen and from rat liver with a thiol-specific two-protonic-state reactivity probe (2,2′-dipyridyl disulphide) and with a specific synthetic substrate (N-benzyloxy-carbonyl-L-arginyl-L-arginine-2-naphthylamide). Biochem. J. 222:805-14
104. 104. Willstätter R, Bamann E. 1929. Uber die proteasen der magenschleimhaut. Hoppe-Seyler's Z. Physiol. Chem. 180:127-43
105. 105. Yagel S, Warner AH, Nellans HN, Lala PK, Waghorne C, et al. 1989. Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells. Cancer Res. 49:3553-57
106. 106. Yamamoto A, Hara T, Tomoo K, Ishida T, Fujii T, et al. 1997. Binding mode of CA074, a specific irreversible inhibitor, to bovine cathepsin B as determined by X-ray crystal analysis of the complex. J. Biochem. 121:974-47
107. 107. Yamamoto A, Tomoo K, Doi M, Ohishi H, Inoue M, et al. 1992. Crystal structure of papain-succinyl-Gln-Val-Val-Ala-Ala-p-Nitroanilide complex at 1.7 Å: noncovalent binding mode of a common sequence of endogenous thiol protease inhibitors. Biochemistry 31:11305-9
108. 108. Yamamoto D, Matsumoto K, Ohishi H, Tshida T, Inoue M, et al. 1991. Refined X-ray structure of papain:E64c complex at 2.1 Å resolution. J. Biol. Chem. 266:14771-57
109. 109. Yamashita DS, Smith WW, Zhao B, Janson CA, Tomaszek TA, et al. 1997. Structure and design of potent and selective cathepsin K inhibitors. J. Am. Chem. Soc. 119:11351-52
110. 110. Yan S, Sameni M, Sloane BF. 1998. Cathepsin B and human tumor progression. Biol. Chem. 379:113-23
111. 111. Yang Y, Wells WW. 1991. Identification and characterization of the functional amino acids at the active center of pig liver thioltransferase by site-directed mutagenesis. J. Biol. Chem. 166:12759-65
112. 112. Zhao B, Janson CA, Amegadzie BY, D'Allessio K, Griffin C, et al. 1997. Crystal structure of human osteoclast cathepsin K complex with E-64. Nat. Struct. Biol. 4:109-11